Pharmaceutical and biomedical applications of surface engineered carbon nanotubes
- PMID: 25601411
- PMCID: PMC7108288
- DOI: 10.1016/j.drudis.2015.01.006
Pharmaceutical and biomedical applications of surface engineered carbon nanotubes
Abstract
Surface engineered carbon nanotubes (CNTs) are attracting recent attention of scientists owing to their vivid biomedical and pharmaceutical applications. The focus of this review is to highlight the important role of surface engineered CNTs in the highly challenging but rewarding area of nanotechnology. The major strength of this review lies in highlighting the exciting applications of CNTs to boost the research efforts, which unfortunately are otherwise scattered in the literature making the reading non-coherent and non-homogeneous.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Figures




Similar articles
-
Carbon nanotubes for the delivery of therapeutic molecules.Expert Opin Drug Deliv. 2004 Nov;1(1):57-65. doi: 10.1517/17425247.1.1.57. Expert Opin Drug Deliv. 2004. PMID: 16296720 Review.
-
Recent advances in drug delivery: potential and limitations of carbon nanotubes.Recent Pat Drug Deliv Formul. 2007;1(3):214-21. doi: 10.2174/187221107782331601. Recent Pat Drug Deliv Formul. 2007. PMID: 19075888 Review.
-
Nanospray Drying Technology: Existing Limitations and Future Challenges.Recent Pat Drug Deliv Formul. 2015;9(3):185-6. doi: 10.2174/1872211309666150513111150. Recent Pat Drug Deliv Formul. 2015. PMID: 25966873 No abstract available.
-
Advancement in carbon nanotubes: basics, biomedical applications and toxicity.J Pharm Pharmacol. 2011 Feb;63(2):141-63. doi: 10.1111/j.2042-7158.2010.01167.x. Epub 2010 Nov 16. J Pharm Pharmacol. 2011. PMID: 21235578 Review.
-
Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.Drug Discov Today. 2007 Aug;12(15-16):650-6. doi: 10.1016/j.drudis.2007.06.002. Epub 2007 Jul 31. Drug Discov Today. 2007. PMID: 17706547 Review.
Cited by
-
Biological Response to Carbon-Family Nanomaterials: Interactions at the Nano-Bio Interface.Front Bioeng Biotechnol. 2019 Jan 23;7:4. doi: 10.3389/fbioe.2019.00004. eCollection 2019. Front Bioeng Biotechnol. 2019. PMID: 30729107 Free PMC article. Review.
-
Advances and Perspectives in the Use of Carbon Nanotubes in Vaccine Development.Int J Nanomedicine. 2021 Aug 12;16:5411-5435. doi: 10.2147/IJN.S314308. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34408416 Free PMC article. Review.
-
An Overview of Antimicrobial Properties of Carbon Nanotubes-Based Nanocomposites.Adv Pharm Bull. 2022 May;12(3):449-465. doi: 10.34172/apb.2022.049. Epub 2021 Jul 3. Adv Pharm Bull. 2022. PMID: 35935059 Free PMC article. Review.
-
Ligand-conjugated multiwalled carbon nanotubes for cancer targeted drug delivery.Front Pharmacol. 2024 Jul 25;15:1417399. doi: 10.3389/fphar.2024.1417399. eCollection 2024. Front Pharmacol. 2024. PMID: 39119607 Free PMC article. Review.
-
Preliminary study on conjugation of formononetin with multiwalled carbon nanotubes for inducing apoptosis via ROS production in HeLa cells.Drug Des Devel Ther. 2018 Sep 7;12:2815-2826. doi: 10.2147/DDDT.S169767. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30233144 Free PMC article.
References
-
- Gupta R. Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage. Pharm. Res. 2013;31:322–334. - PubMed
-
- Brahmachari S. Biotinylated amphiphile-single walled carbon nanotubes conjugate for target-specific delivery to cancer cells. J. Mater. Chem. B. 2014;2:1160–1173. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical